| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains
Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations
Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter
Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally
Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion
DEFINE AFib results at AF Symposium 2025: First-of-its-kind app-based study uses AF burden data to identify patients at high risk for AF-related healthcare utilization
LINQ™ insertable cardiac monitors showed 4 times greater episode sensitivity compared to Apple Watch™*
Medtronic, a global leader in healthcare technology, announced that it has received the prestigious Great Place to Work® certification in the mid-size organization...
Agreement includes option to acquire the company